Propylthiouracil-induced diffuse proliferative lupus nephritis: review of immunological complications

J Am Soc Nephrol. 1997 Jul;8(7):1205-10. doi: 10.1681/ASN.V871205.

Abstract

Propylthiouracil (PTU), used to treat Graves' disease, occasionally induces a lupus-like syndrome. A 39-year-old woman developed clinical manifestations of systemic lupus erythematosus with rash, serositis, myocarditis, and acute renal insufficiency, associated with serologies for lupus, after 3 wk of exposure to the drug. Renal biopsy revealed diffuse proliferative lupus nephritis. This article reviews the side effects of PTU and the literature on PTU-induced nephrotoxicity. Possible mechanisms and management of drug-induced lupus nephritis are also reviewed. To facilitate early and specific intervention, clinicians should be aware of the propensity of PTU to cause lupus-like syndromes with renal involvement.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Antigen-Antibody Complex / metabolism
  • Antithyroid Agents / adverse effects*
  • Female
  • Fluorescent Antibody Technique, Direct
  • Graves Disease / drug therapy
  • Humans
  • Kidney / drug effects
  • Kidney / immunology
  • Kidney / pathology
  • Lupus Nephritis / chemically induced*
  • Lupus Nephritis / immunology
  • Lupus Nephritis / pathology
  • Propylthiouracil / adverse effects*

Substances

  • Antigen-Antibody Complex
  • Antithyroid Agents
  • Propylthiouracil